格隆汇8月27日｜东海证券研报指出，国际医学2025年H1实现营收20.34亿元（同比-15.95%），收入端 承压的主要原因在于DRG/DIP支付方式改革深化导致住院次均费用下降影响；归母净利润-1.65亿元 （同比减亏4.98%）。分季度看，公司经营环比改善显著，2025年Q2归母净利润-0.59亿元（同比、环比 分别减亏14.68%、44.89%）。门急诊服务总量达131.91万人次，同比增长5.42%；住院服务量9.63万人 次，同比减少4.01%，主要受医保支付结构调整影响所致。公司将重点做好业务结构调整、消费类医疗 布局等措施，同步进行成本管控、提升服务效能，更加适应政策变化，推动降本增效成果显现。公司积 极探索"综合医疗+特色专科"的创新业务模式，在医美整形、康复等特色专科进行布局，核心竞争力不 断增强，盈利能力持续提升。维持"买入"评级。 ...

证券代码：000516 证券简称：国际医学 编号：2025-04 西安国际医学投资股份有限公司投资者关系活动记录表 | | 特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 业绩说明会 | | 投资者关系活动 | □新闻发布会 路演活动 | | 类别 | | | | 现场参观 | | | 其他_____ | | 参与单位名称及 | 天风证券杨松、李慧瑶，中信建投证券贺菊颖、王在存、华冉， | | | 国盛证券徐雨涵，兴业证券孙媛媛、黄翰漾、东楠，东北证券文 | | 人员姓名 | 将儒，广发证券王少喆，西部证券吕晔，申万宏源证券张静含、 | | | 余玉君，开源证券阮帅，华创证券王港，华创证券孙芊荟，华创 | | | 证券郑辰、王宏雨，招商证券梁广楷、张语馨，东海证券杜永宏、 | | | 赖菲虹，华泰证券代雯、沈卢庆、孙茗馨，华福证券陈铁林、何 | | | 展聪，中信证券陈竹、宋硕、沈睦钧、魏巍，华安证券李雨涵， | | | 东吴证券冉胜男，东方证券王光宇，东北证券古翰羲，长江证券 | | | 盛夏，国海证券李明，国融证券王林，中金公司张一弛，招银国 | | | 际黄本晨 ...

Group 1: 2024 Overall Business Performance - The company achieved a total outpatient and emergency service volume of 2.5727 million, a year-on-year increase of 7.70% [1] - The inpatient service volume reached 205,700, reflecting a year-on-year growth of 10.73% [1] - The total operating revenue for the year was 4.815 billion, with a year-on-year increase of 4.28% [2] - The net profit attributable to the parent company was -254 million, a reduction in loss by 31.01% [2] Group 2: Q1 2025 Business Performance - In Q1 2025, the company reported an operating revenue of 999.7 million, a decrease of 14.99% compared to the same period last year [3] - The net profit attributable to the parent company was -106 million, a decline of 1.37% year-on-year [3] - The net operating cash flow was 244 million, indicating stable cash flow management [3] Group 3: 2024 Operational Highlights - Xi'an High-tech Hospital generated operating revenue of 1.525 billion, a year-on-year increase of 2.68% [3] - Xi'an International Medical Center Hospital achieved operating revenue of 3.274 billion, with a year-on-year growth of 7.60% [3] - The outpatient and emergency service volume at the International Medical Center Hospital reached 1.4182 million, a year-on-year increase of 18.88% [4] - The inpatient service volume was 139,700, reflecting a year-on-year growth of 15.32% [4] Group 4: Proton Center Project and Digitalization - The proton therapy center project is progressing, with the core component, the cyclotron, installed by June 18, 2024, and expected to be operational by the end of 2025 [5][6] - The company has completed local deployment of medical intelligent models, integrating with core business systems to enhance operational efficiency [7] Group 5: Quality Improvement and Service Expansion - The hospital is advancing its three-tier evaluation work, focusing on system optimization and quality enhancement [8] - The company is expanding into high-end medical services, including aesthetic medicine, rehabilitation, and proton therapy, to meet diverse health needs [9] - The company is adapting to ongoing healthcare policy reforms by refining operations and adjusting business structures to maintain service quality [10]